Abstract
Cancer arises as the result of sequential alterations in growth-controlling genes. Epigenetic factors, such as angiogenesis and surrounding micro-environment can also affect cancer initiation and progression. Tumorigenesis is accompanied by important changes in gene expression in the tumor cell as compared to its normal counterpart. The advent of powerful new techniques such as microarray technology and SAGE has allowed the study of gene expression in neoplastic cells at a scale never before accomplished. Indeed, it is now possible to efficiently measure the levels of thousands of genes expressed in normal and tumor tissues. This global knowledge of gene expression allows the identification of differentially expressed genes and, in principle, the understanding of the complex molecular circuitry regulating normal and neoplastic growth. Such studies have led to molecular profiling of tumors, which have suggested general methods for distinguishing tumors of various biological behaviors (molecular classi fication), elucidating pathways relevant to the tumorigenesis process, and identifying targets for the detection (biomarkers) and mechanism-based therapy of cancer. The next challenge will be the implementation of these breakthroughs in the clinic, as well as the extension of these paradigms to the fields of proteomics and physiomics.
Current Genomics
Title: Functional Genomics Approaches in Cancer Research
Volume: 3 Issue: 5
Author(s): Patrice J. Morin
Affiliation:
Abstract: Cancer arises as the result of sequential alterations in growth-controlling genes. Epigenetic factors, such as angiogenesis and surrounding micro-environment can also affect cancer initiation and progression. Tumorigenesis is accompanied by important changes in gene expression in the tumor cell as compared to its normal counterpart. The advent of powerful new techniques such as microarray technology and SAGE has allowed the study of gene expression in neoplastic cells at a scale never before accomplished. Indeed, it is now possible to efficiently measure the levels of thousands of genes expressed in normal and tumor tissues. This global knowledge of gene expression allows the identification of differentially expressed genes and, in principle, the understanding of the complex molecular circuitry regulating normal and neoplastic growth. Such studies have led to molecular profiling of tumors, which have suggested general methods for distinguishing tumors of various biological behaviors (molecular classi fication), elucidating pathways relevant to the tumorigenesis process, and identifying targets for the detection (biomarkers) and mechanism-based therapy of cancer. The next challenge will be the implementation of these breakthroughs in the clinic, as well as the extension of these paradigms to the fields of proteomics and physiomics.
Export Options
About this article
Cite this article as:
Morin J. Patrice, Functional Genomics Approaches in Cancer Research, Current Genomics 2002; 3 (5) . https://dx.doi.org/10.2174/1389202023350309
DOI https://dx.doi.org/10.2174/1389202023350309 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Flavonoid-Based Cancer Therapy: An Updated Review
Anti-Cancer Agents in Medicinal Chemistry SUBJECT INDEX TO VOLUME 1
Current Drug Safety Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor
Current Molecular Pharmacology Discovery of Biomarkers in Hepatocellular Carcinoma Metastasis Using Bioinformatic Analysis
Current Bioinformatics TGF-β1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis
Current Pharmaceutical Design Redox Environment and its Meaning for Breast Cancer Cells Fate
Current Cancer Drug Targets The Chemopreventive and Chemotherapeutic Potentials of Tea Polyphenols
Current Pharmaceutical Biotechnology Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs
Current Drug Targets Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Targeted Therapies in Gynecologic Cancers
Current Cancer Drug Targets Fluorescein Fluorescence Use in the Management of Intracranial Neoplastic and Vascular Lesions: A Review and Report of a New Technique
Current Drug Discovery Technologies Activatable Optical Probes for the Detection of Enzymes
Current Organic Synthesis Systemic Therapeutic Gene Delivery for Cancer: Crafting Paris Arrow
Current Gene Therapy Editorial [Hot Topic: Nongenomic Effects of Thyroid Hormones in Central Nervous System and Skeletal Muscle (Guest Editor: Sandra Incerpi)]
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Application of Nanomaterials in Stem Cell Therapy for Some Neurological Diseases
Current Drug Targets Modulation of intracellular pH in human ovarian cancer.
Current Molecular Medicine Novel Gastrin Receptor-Directed Contrast Agents - Potential in Brain Tumor Magnetic Resonance Imaging
Medicinal Chemistry Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy
Current Cancer Drug Targets An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-Glycoprotein
Current Cancer Drug Targets Andrographolide Inhibits Osteopontin Expression and Breast Tumor Growth Through Down Regulation of PI3 Kinase/Akt Signaling Pathway
Current Molecular Medicine